Cohlhepp Ryan

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 13. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 13
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Bicara Therapeutics Inc.President, COO & Interim CEOOption exercisenothing paid17,500 sharesSep 10, 2026Bicara Therapeutics Inc.President, COO & Interim CEOnothing paidExercise · Sep 10Option exercise17,500Sep 10, 2026
Bicara Therapeutics Inc.President, COO & Interim CEOOpen-market sell$80,6633,442 sharesSep 10, 2026Bicara Therapeutics Inc.President, COO & Interim CEO$80,663Sell · Sep 10Open-market sell3,442Sep 10, 2026
Bicara Therapeutics Inc.President, COO & Interim CEOOpen-market sell$320,05314,058 sharesSep 10, 2026Bicara Therapeutics Inc.President, COO & Interim CEO$320,053Sell · Sep 10Open-market sell14,058Sep 10, 2026
Bicara Therapeutics Inc.President, COO & Interim CEOOption exercise$66,32217,500 sharesSep 10, 2026Bicara Therapeutics Inc.President, COO & Interim CEO$66,322Exercise · Sep 10Option exercise17,500Sep 10, 2026
Bicara Therapeutics Inc.President and COOOption exercisenothing paid18,750 sharesAug 12, 2026Bicara Therapeutics Inc.President and COOnothing paidExercise · Aug 12Option exercise18,750Aug 12, 2026